CYBA and ovarian carcinoma: Inhibition of p22phox showed the profound effects in retarding ovarian cancer cell proliferation and tumorigenesis in vitro and in vivo, complementing its biological function via influencing the proteasome ubiquitination and subsequent proteasome-dependent degradation of p53.